Salveo backs cannabis biotech in $10m Series A

Managing partner Jeffrey Howard says Front Range Biosciences is among the companies benefiting from a surge in private investor interest in cannabis.

To view this content you must sign in:

Not yet registered? Join today to access Agri Investor's industry insights and updates.